- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02144454
Impact of Meal Fatty Acids on Postprandial Vascular Reactivity (DIVAS-2)
December 2, 2015 updated by: Julie Lovegrove, University of Reading
The Acute Effects of Meals Rich in Saturated, Monounsaturated and n-6 Polyunsaturated Fatty Acids on Vascular Function
Cardiovascular disease (CVD) is the leading cause of death in women.
Premenopausal women have a lower risk of CVD compared with men of a similar age.
However, the incidence of CVD increases greatly after the menopause.
The risk of heart disease is strongly associated with the health of an individual's blood vessels.
It is thought that changes to the type of fat the investigators eat in their diet may affect the normal functioning and elasticity of the blood vessels, as well as affect cholesterol levels in the blood.
Types of fat in the diet include monounsaturated fats (found mainly in olive oil), n-6 polyunsaturated fats (found mainly in sunflower oil) and saturated fats (found mainly in dairy products, such as butter and cheese).
Since the investigators are in the fed (or postprandial) state for up to 18 hours of the day, it is important to see how these different fats affect the investigators blood vessels and blood fats over the course of the day after eating a meal.
The aim of this study is to determine how consuming meals rich in saturated fats, n-6 polyunsaturated fats or monounsaturated fats influence the normal functioning and elasticity of the blood vessels throughout the day in postmenopausal women.
A secondary aim is to determine the effects of these different dietary fats on a range of accepted heart disease risk markers including circulating levels of fats (lipids) and glucose in the blood.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 6AP
- University of Reading
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Postmenopausal (not menstruated for at least 1 year)
- Plasma triacylglycerol (TAG) between 0.8 and 4.0 mmol/l
- Body mass index (BMI) between 18-35 kg/m2
- Total cholesterol (TC): <8 mmol/l
- Systolic blood pressure <160 mmHg and diastolic blood pressure <100 mmHg
- Non-smoker
Exclusion Criteria:
- Having suffered a myocardial infarction/stroke in the past 12 months
- Diabetic (diagnosed as fasting blood glucose >7 mmol/l) or suffering from other endocrine disorders
- Suffering from renal or bowel disease or have a history of cholestatic liver or pancreatitis
- On drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
- History of alcohol abuse
- On hormone replacement therapy (HRT)
- Planning or on a weight reducing regime
- Taking nutritional supplements (e.g. fish oil, calcium)
- Anaemic: haemoglobin <11.5 g/dl
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Meal rich in saturated fats
Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in saturated fats
|
Other Names:
|
|
Experimental: Meal rich in monounsaturated fats
Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in monounsaturated fats
|
Other Names:
|
|
Experimental: Meal rich in n-6 polyunsaturated fats
Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in n-6 polyunsaturated fats
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in vascular reactivity measured by flow-mediated dilatation (FMD)
Time Frame: Acute study: measured at 0 (baseline), 180, 300 and 420 min
|
Acute study: measured at 0 (baseline), 180, 300 and 420 min
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in vascular reactivity measured by laser Doppler imaging with iontophoresis of acetylcholine (endothelium-dependent) and sodium nitroprusside (endothelium-independent)
Time Frame: Acute study: measured at 0 (baseline), 240 and 450 min
|
Acute study: measured at 0 (baseline), 240 and 450 min
|
|
Change from baseline in plasma lipids (primarily triacylglycerol, apolipoprotein B and non-esterified fatty acids)
Time Frame: Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
|
Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
|
|
Change from baseline in arterial stiffness measured by digital volume pulse (stiffness index and reflection index)
Time Frame: Acute study: taken at 0 (baseline), 240 amd 450 min
|
Acute study: taken at 0 (baseline), 240 amd 450 min
|
|
Change from baseline in blood pressure (systolic blood pressure, diastolic blood pressure and pulse pressure)
Time Frame: Acute study: taken at 0 (baseline), 240 and 450 min
|
Acute study: taken at 0 (baseline), 240 and 450 min
|
|
Change from baseline in markers of insulin resistance (glucose, insulin, indices of insulin resistance/sensitivity)
Time Frame: Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
|
Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
|
|
Change from baseline in nitric oxide (total plasma nitrates and nitrites)
Time Frame: Acute study: 0 (baseline), 180, 300 and 420 min
|
Acute study: 0 (baseline), 180, 300 and 420 min
|
|
Change from baseline in plasma markers of endothelial activation (e.g. E-selectin, P-selectin, vascular cell adhesion molecule (VCAM-1))
Time Frame: Acute study: 0 (baseline), 180, 300 and 420 min
|
Acute study: 0 (baseline), 180, 300 and 420 min
|
|
Change from baseline in plasma phospholipid fatty acid composition
Time Frame: Acute study: 0 (baseline), 180, 300 and 420 min
|
Acute study: 0 (baseline), 180, 300 and 420 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Rathnayake KM, Weech M, Lovegrove JA, Jackson KG. Glu298Asp (rs1799983) Polymorphism Influences Postprandial Vascular Reactivity and the Insulin Response to Meals of Varying Fat Composition in Postmenopausal Women: Findings from the Randomized, Controlled Dietary Intervention and VAScular function (DIVAS)-2 Study. J Nutr. 2021 Apr 8;151(4):848-856. doi: 10.1093/jn/nxaa394.
- Rathnayake KM, Weech M, Jackson KG, Lovegrove JA. Meal Fatty Acids Have Differential Effects on Postprandial Blood Pressure and Biomarkers of Endothelial Function but Not Vascular Reactivity in Postmenopausal Women in the Randomized Controlled Dietary Intervention and VAScular function (DIVAS)-2 Study. J Nutr. 2018 Mar 1;148(3):348-357. doi: 10.1093/jn/nxx042.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
May 15, 2014
First Submitted That Met QC Criteria
May 21, 2014
First Posted (Estimate)
May 22, 2014
Study Record Updates
Last Update Posted (Estimate)
December 3, 2015
Last Update Submitted That Met QC Criteria
December 2, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 024/0036
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on Saturated fat
-
Oslo University HospitalCompletedCardiovascular Disease | Cardiovascular Risk Factors | Dietary ModificationNorway
-
UCSF Benioff Children's Hospital OaklandNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedInflammation | Cardiovascular Disease | Insulin Resistance | DyslipidemiaUnited States
-
UCSF Benioff Children's Hospital OaklandNational Cattlemen's Beef AssociationCompletedHealthy | Cardiovascular Disease | Atherogenic DyslipidemiaUnited States
-
UCSF Benioff Children's Hospital OaklandDairy Management Inc.CompletedDyslipidemiaUnited States
-
University of WashingtonVA Puget Sound Health Care SystemCompleted
-
Medical College of WisconsinCompletedPeripheral Vascular Disease | Endothelial Dysfunction | Lipid DisorderUnited States
-
Shahid Beheshti UniversityCompleted
-
Kevin DavyAmerican Diabetes AssociationCompleted
-
University of ReadingWellcome TrustCompletedCardiovascular DiseasesUnited Kingdom
-
Oslo Metropolitan UniversityUniversity of Oslo; Nofima; Mills DACompletedGut Microbiota | Satiety | Postprandial Blood GlucoseNorway